328 related articles for article (PubMed ID: 25557289)
41. Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
Al-Azzawi H; Yacqub-Usman K; Richardson A; Hofland LJ; Clayton RN; Farrell WE
Endocrinology; 2011 Feb; 152(2):364-73. PubMed ID: 21177832
[TBL] [Abstract][Full Text] [Related]
42. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
43. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
44. HMGA1 and HMGA2 rearrangements in mass-forming endometriosis.
Medeiros F; Araujo AR; Erickson-Johnson MR; Kashyap PC; Dal Cin P; Nucci M; Wang X; Bell DA; Oliveira AM
Genes Chromosomes Cancer; 2010 Jul; 49(7):630-4. PubMed ID: 20461755
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas.
Qian ZR; Asa SL; Siomi H; Siomi MC; Yoshimoto K; Yamada S; Wang EL; Rahman MM; Inoue H; Itakura M; Kudo E; Sano T
Mod Pathol; 2009 Mar; 22(3):431-41. PubMed ID: 19136928
[TBL] [Abstract][Full Text] [Related]
46. HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells.
Parisi S; Piscitelli S; Passaro F; Russo T
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935816
[TBL] [Abstract][Full Text] [Related]
47. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.
D'Angelo D; Esposito F; Fusco A
Front Med (Lausanne); 2015; 2():39. PubMed ID: 26137461
[TBL] [Abstract][Full Text] [Related]
49. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.
Zhu X; Mao X; Hurren R; Schimmer AD; Ezzat S; Asa SL
J Clin Endocrinol Metab; 2008 Sep; 93(9):3610-7. PubMed ID: 18544619
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
[TBL] [Abstract][Full Text] [Related]
51. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.
Sgarra R; Pegoraro S; Ros G; Penzo C; Chiefari E; Foti D; Brunetti A; Manfioletti G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):216-229. PubMed ID: 29518471
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of miR-410 targeting the cyclin B1 gene plays a role in pituitary gonadotroph tumors.
Müssnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Wierinckx A; Trouillas J; Fusco A; D'Angelo D
Cell Cycle; 2015; 14(16):2590-7. PubMed ID: 26125663
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of microRNA expression in colorectal cancer.
Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
[TBL] [Abstract][Full Text] [Related]
54. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
55. Chromatin remodeling and histone modifications in pituitary tumors.
Tateno T; Zhu X; Asa SL; Ezzat S
Mol Cell Endocrinol; 2010 Sep; 326(1-2):66-70. PubMed ID: 20060434
[TBL] [Abstract][Full Text] [Related]
56. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
57. HMGA and cancer.
Fedele M; Fusco A
Biochim Biophys Acta; 2010; 1799(1-2):48-54. PubMed ID: 20123067
[TBL] [Abstract][Full Text] [Related]
58. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
59. Strategies to use microRNAs as therapeutic targets.
Gentilin E; Degli Uberti E; Zatelli MC
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):629-639. PubMed ID: 27923456
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]